RETRACTED ARTICLE:Steroid receptor co-activator-3 promotes osteosarcoma progression through up-regulation of FoxM1

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 3087-3094

  Geng, Shuo ^a   Wang, Xiaoyu ^a   Xu, Xiaoyan ^a   Zhang, Hepeng ^a   Ma, Yan ^a   Zhang, Yunqi ^a   Li, Baoxin ^b   Bi, Zhenggang ^a   Yang, Chenglin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

C EBP ; FoxM1; Osteosarcoma; SRC 3; Transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN FOXM1; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BINDING SITES; BONE NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; DISEASE PROGRESSION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NUCLEAR RECEPTOR COACTIVATOR 3; OSTEOSARCOMA; PROMOTER REGIONS, GENETIC; UP-REGULATION;

EID: 84898772940     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1406-7     Document Type: TB

References (24)

1. Luo Y, Deng Z, Chen J. Pivotal regulatory network and genes in osteosarcoma. Arch Med Sci. 2013;9:569-75.
2. Poos K, Smida J, Nathrath M, Maugg D, Baumhoer D, et al. How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation. PLoS Comput Biol. 2013;9:e1003210.
3. Xu J, Wu RC, O'Malley BW. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer. 2009;9:615-30.
4. Gojis O, Rudraraju B, Gudi M, Hogben K, Sousha S, et al. The role of SRC-3 in human breast cancer. Nat Rev Clin Oncol. 2010;7:83-9.
5. York B, Yu C, Sagen JV, Liu Z, Nikolai BC, et al. Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology. Proc Natl Acad Sci U S A. 2010;107:11122-7.
6. York B, O'Malley BW. Steroid receptor coactivator (SRC) family: masters of systems biology. J Biol Chem. 2010;285:38743-50.
7. Johnson AB, O'Malley BW. Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy. Mol Cell Endocrinol. 2012;348:430-9.
8. Walsh CA, Qin L, Tien JC, Young LS, Xu J. The function of steroid receptor coactivator-1 in normal tissues and cancer. Int J Biol Sci. 2012;8:470-85.
9. McBryan J, Theissen SM, Byrne C, Hughes E, Cocchiglia S, et al. Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1. Cancer Res. 2012;72:548-59.
10. Agoulnik IU, Weigel NL. Androgen receptor coactivators and prostate cancer. Adv Exp Med Biol. 2008;617:245-55.
11. Long W, Foulds CE, Qin J, Liu J, Ding C, et al. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J Clin Invest. 2012;122:1869-80.
12. Wang Y, Lonard DM, Yu Y, Chow DC, Palzkill TG, et al. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. Mol Endocrinol. 2011;25:2041-53.
13. Mussi P, Yu C, O'Malley BW, Xu J. Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3. Mol Endocrinol. 2006;20:3105-19.
14. Liontos M, Niforou K, Velimezi G, Vougas K, Evangelou K, et al. Modulation of the E2F1-driven cancer cell fate by the DNA damage response machinery and potential novel E2F1 targets in osteosarcomas. Am J Pathol. 2009;175:376-91.
15. Jin R, Sun Y, Qi X, Zhang H, Zhang Y, et al. E2F1 is involved in DNA single-strand break repair through cell-cycle-dependent upregulation of XRCC1 expression. DNA Repair (Amst). 2011;10:926-33.
16. Wu RC, Qin J, Yi P, Wong J, Tsai SY, et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell. 2004;15:937-49.
17. Li S, Shang Y. Regulation of SRC family coactivators by post-translational modifications. Cell Signal. 2007;19:1101-12.
18. Li X, Lonard DM, Jung SY, Malovannaya A, Feng Q, et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell. 2006;124:381-92.
19. Wu RC, Feng Q, Lonard DM, O'Malley BW. SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell. 2007;129:1125-40.
20. Radhakrishnan SK, Bhat UG, Hughes DE, Wang IC, Costa RH, et al. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Cancer Res. 2006;66:9731-5.
21. Teh MT, Gemenetzidis E, Chaplin T, Young BD, Philpott MP. Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes. Mol Cancer. 2010;9:45.
22. Li Q, Zhang N, Jia Z, Le X, Dai B, et al. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res. 2009;69:3501-9.
23. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol. 2005;25:10875-94.
24. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, et al. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem. 2008;283:20770-8.